536971-53-6
Chemical Structure
F3 peptide
- CAS No.: 536971-53-6
- Formula:C152H263N49O41
- Molecular Weight:3433.02
SMILES: O=C(N[C@@H](CC(O)=O)C(N[C@@H](CCC(O)=O)C(N1[C@@H](CCC1)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CO)C(N[C@@H](C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@@H](C)C(N[C@@H](CCCCN)C(N2[C@@H](CCC2)C(N[C@@H](C)C(N3[C@@H](CCC3)C(N4[C@@H](CCC4)C(N[C@@H](CCCCN)C(N5[C@@H](CCC5)C(N[C@@H](CCC(O)=O)C(N6[C@@H](CCC6)C(N[C@@H](CCCCN)C(N7[C@@H](CCC7)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N[C@@H](C)C(N8[C@@H](CCC8)C(N[C@@H](C)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CCCCN)N
Biological Activity: F3 peptide is a fragment of the human high mobility group protein 2 (HMGB2), and can specifically bind to nucleolin expressed on the membrane of cancer cells, neovasculature, and endothelium. F3 peptide can be used as an effective ligand to improve their druggability of macromolecular drugs or nanoparticles, and so on[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
F3 peptide | F3 peptide is a fragment of the human high mobility group protein 2 (HMGB2), and can specifically bind to nucleolin expressed on the membrane of cancer cells, neovasculature, and endothelium. F3 peptide can be used as an effective ligand to improve their druggability of macromolecular drugs or nanoparticles, and so on. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Hu Q, et al. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Biomaterials. 2013 Jan;34(4):1135-45. [Content Brief]
- [2]. Ham SH, et al. Molecular tumor targeting of gelonin by fusion with F3 peptide. Acta Pharmacol Sin. 2017 Jun;38(6):897-906. [Content Brief]
- [3]. Tao Z, et al. Multivalent assembly of nucleolin-targeted F3 peptide potentiates TRAIL's tumor penetration and antitumor effects. J Control Release. 2025 Jul 10;383:113835. [Content Brief]
Keywords